1. Home
  2. DCO vs VRDN Comparison

DCO vs VRDN Comparison

Compare DCO & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ducommun Incorporated

DCO

Ducommun Incorporated

HOLD

Current Price

$160.70

Market Cap

2.6B

Sector

Industrials

ML Signal

HOLD

Logo Viridian Therapeutics Inc.

VRDN

Viridian Therapeutics Inc.

HOLD

Current Price

$21.56

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCO
VRDN
Founded
1849
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.1B
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
DCO
VRDN
Price
$160.70
$21.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
14
Target Price
$153.60
$35.46
AVG Volume (30 Days)
160.6K
1.2M
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.95
N/A
Revenue
$824,730,000.00
$5,706,000.00
Revenue This Year
$7.40
$13.73
Revenue Next Year
$8.59
$279.00
P/E Ratio
$88.58
N/A
Revenue Growth
4.85
N/A
52 Week Low
$84.76
$13.18
52 Week High
$210.39
$34.29

Technical Indicators

Market Signals
Indicator
DCO
VRDN
Relative Strength Index (RSI) 37.43 47.84
Support Level $161.52 $21.62
Resistance Level $168.74 $24.86
Average True Range (ATR) 5.91 0.85
MACD -1.46 -0.34
Stochastic Oscillator 12.28 28.08

Price Performance

Historical Comparison
DCO
VRDN

About DCO Ducommun Incorporated

Ducommun Inc provides engineering & manufacturing services for high-performance products & high-cost-of failure applications used in the aerospace and defense, industrial, medical & other industries. The company's reportable segments are Structural Systems & Electronic Systems. Structural Systems designs, engineers, and manufactures various sizes of complex contoured aerostructure components and assemblies, and supplies composite and metal-bonded structures and assemblies. Electronic Systems designs, engineers and manufactures high-reliability electronic and electromechanical products used in technology-driven markets, including A&D and Industrial end-use markets. It generates a maximum of its revenue from the Electronic Systems.

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. The company is developing two anti-IGF-1R product candidates, veligrotug for intravenous (IV) administration and elegrobart (formerly VRDN-003) for subcutaneous (SC) administration, to treat patients with TED. Our most advance program, veligrotug, is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of TED.

Share on Social Networks: